Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
204 Leser
Artikel bewerten:
(1)

Vheda Health Closes Record 2025 with Market-Leading Outcomes, New Partnerships, and Workforce Growth

In 2025, Vheda Health achieved its largest growth on record - launching its chronic, behavioral health, and maternity programs across six new markets - driving 2,001% revenue growth and a 4,049% membership increase since 2021 through consistent 80%+ engagement and double-digit medical cost savings, reinforcing its leadership as the premier virtual health engagement solution for Medicaid, Medicare, and SNP health plans.

COLUMBIA, MARYLAND / ACCESS Newswire / January 13, 2026 / Vheda Health, a nationally certified Minority Business and leader in virtual health engagement, concludes 2025 with record gains through new and expanded health plan partnerships, educational leadership, and workforce growth. As a result, the company gained national recognition as the go-to partner for Medicaid, Medicare, and SNP plans seeking to accelerate health equity for everyone by providing simple access to care from anywhere.

"The close of each year brings reflection and 2025 was a defining year for Vheda Health," said Shameet Luhar, CEO and Co-Founder of Vheda Health. "From launching partnerships with new states and health plans, to receiving national recognition for Vheda's workplace culture, 2026 will be the year Vheda becomes the destination health plan partner and employer for members and employees across the country."

Vheda Health's 2025 Accomplishments include:

6 National Program Launches

  • New National Partnerships: 40%+ member growth through new and expanded chronic, behavioral, and maternal programs in 6 states, including California, Iowa, Pennsylvania, Louisiana, New Mexico, and Oklahoma.

Actuarially Validated Health Plan Outcomes

  • Increased medical cost reduction and utilization impact: $600-$1,150+ PMPM savings, driving 32-34%reduction in inpatient spend.

  • Positive maternal health outcomes: 38.6 weeks average gestation at delivery, 83% postpartum care completion.

  • Sustained monthly member engagement: 80%+ member engagement and device adherence.

  • Higher STAR ratings: Delivered statistically significant HEDIS gains by improving core measures from below the 10th NCQA percentile to above the 50th, 75th, and 95th percentile, for Breast Cancer Screening (BCS-E), Controlling Blood Pressure (CBP), Statin Therapy for Patients with Cardiovascular Disease (SPC), Statin Therapy for Patients with Diabetes (SPD), and Adults' Access to Preventive/Ambulatory Health Services (AAP).

Educational Leadership Addressing Key Health Plan Challenges

  • National thought leadership: Delivered a 2025 educational series with webinars, expert sessions, and a maternal health spotlight featuring Dr. Debra Jones, alongside the Vheda explainer video, "The Vheda Blueprint - Engagement. ROI. Outcomes."

  • Vheda Insider launch: Introduced the Vheda Insider Program, giving health plan executives access to Vheda's webinars, whitepapers, and blueprints on health equity and performance improvement, plus priority access to the 2026 series.

  • 2026 priority series: Announced a 2026 educational series aligned to CMS and state priorities, including maternal health, DSNP transformation, Star Ratings and HEDIS changes, and the ACCESS Model.

Nationally Recognized Growth and Workplace Culture

  • Ranked No. 662 on the 2025 Inc. 5000 list of America's Fastest-Growing Private Companies

  • Named a 2025 Top Workplace by The Baltimore Sun, reinforcing Vheda Health's position as a destination employer for top industry talent.

As we look ahead to 2026 and beyond, our success is only possible because of our clients' trust and our members. Members are the true heartbeat of Vheda Health. They are the reason we get up every day to do what we do. One member shared, "Your company saved my life, if it wasn't for the blood pressure cuff, I would not be here." With this focus, Vheda Health is destined to become the most trusted advisor to Medicaid, Medicare, and SNP health plans nationwide.

About Vheda Health

Vheda Health is the leader in virtual health engagement for health plans supporting underserved populations. With over a decade of experience, our turnkey chronic care, maternal health, and behavioral health programs create a digital extension to your care management team that delivers an outstanding 84% member engagement and an average 3:1 return on investment. The most trusted government payors partner with Vheda Health to create the best healthcare experience that empowers people to live their best life. For more information, watch our 2-minute explainer video at The Vheda Blueprint, visit vheda.com or follow us on LinkedIn.

Contacts:

Media Contact

Kerry Lee Perry
Chief Marketing Officer
Vheda Health
kperry@vheda.com
404-849-1380

SOURCE: Vheda Health



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/vheda-health-closes-record-2025-with-market-leading-outcomes-new-part-1126310

© 2026 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.